Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

This is not a financial advice!

Upcoming catalyst on 31st. of March

I would wait for a pullback to the 1. 20 level for a better entry

Keep an eye on 1.77 level - needs to get broken for a further upmove.

SL under 1.10

TP approx. 2.8

Most info on the chart.

Trade carefully!
הערה
Entry zone is here
עסקה סגורה: הגיע לסטופ
Beyond Technical AnalysisTechnical IndicatorsTrend Analysis

כתב ויתור